nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A4—Fingolimod—multiple sclerosis	0.131	0.213	CbGbCtD
Argatroban—CYP3A4—Methylprednisolone—multiple sclerosis	0.0841	0.137	CbGbCtD
Argatroban—CYP3A5—Dexamethasone—multiple sclerosis	0.0816	0.133	CbGbCtD
Argatroban—CYP3A4—Triamcinolone—multiple sclerosis	0.0638	0.104	CbGbCtD
Argatroban—CYP3A4—Mitoxantrone—multiple sclerosis	0.0614	0.1	CbGbCtD
Argatroban—CYP3A4—Betamethasone—multiple sclerosis	0.0547	0.0893	CbGbCtD
Argatroban—CYP3A4—Prednisolone—multiple sclerosis	0.054	0.0881	CbGbCtD
Argatroban—CYP3A4—Prednisone—multiple sclerosis	0.051	0.0832	CbGbCtD
Argatroban—CYP3A4—Dexamethasone—multiple sclerosis	0.0318	0.0519	CbGbCtD
Argatroban—F2—Cell surface interactions at the vascular wall—SELPLG—multiple sclerosis	0.00308	0.0299	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—CD58—multiple sclerosis	0.00308	0.0299	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—MERTK—multiple sclerosis	0.00308	0.0299	CbGpPWpGaD
Argatroban—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	0.00224	0.0217	CbGpPWpGaD
Argatroban—F2—Syndecan-4-mediated signaling events—CCL5—multiple sclerosis	0.00184	0.0179	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—ICAM1—multiple sclerosis	0.00178	0.0173	CbGpPWpGaD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00161	0.0156	CbGpPWpGaD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00161	0.0156	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—CCL2—multiple sclerosis	0.0016	0.0155	CbGpPWpGaD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00158	0.0154	CbGpPWpGaD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00158	0.0154	CbGpPWpGaD
Argatroban—Haemorrhage—Azathioprine—multiple sclerosis	0.00142	0.005	CcSEcCtD
Argatroban—Pulmonary oedema—Dexamethasone—multiple sclerosis	0.00139	0.0049	CcSEcCtD
Argatroban—Pulmonary oedema—Betamethasone—multiple sclerosis	0.00139	0.0049	CcSEcCtD
Argatroban—Headache—Fingolimod—multiple sclerosis	0.00137	0.00483	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—IFNG—multiple sclerosis	0.00136	0.0132	CbGpPWpGaD
Argatroban—Apnoea—Methotrexate—multiple sclerosis	0.00134	0.00473	CcSEcCtD
Argatroban—F2—Cell surface interactions at the vascular wall—SELE—multiple sclerosis	0.00134	0.013	CbGpPWpGaD
Argatroban—Cough—Cladribine—multiple sclerosis	0.00133	0.00467	CcSEcCtD
Argatroban—Thrombophlebitis—Betamethasone—multiple sclerosis	0.00131	0.00462	CcSEcCtD
Argatroban—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.00131	0.00462	CcSEcCtD
Argatroban—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.00131	0.00461	CcSEcCtD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.0013	0.0126	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.0013	0.0126	CbGpPWpGaD
Argatroban—Cardiac arrest—Prednisolone—multiple sclerosis	0.00129	0.00456	CcSEcCtD
Argatroban—Chest pain—Cladribine—multiple sclerosis	0.00129	0.00456	CcSEcCtD
Argatroban—Pneumonia—Mitoxantrone—multiple sclerosis	0.00129	0.00453	CcSEcCtD
Argatroban—Cardiac failure—Methylprednisolone—multiple sclerosis	0.00128	0.00451	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.00127	0.0123	CbGpPWpGaD
Argatroban—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.00126	0.00444	CcSEcCtD
Argatroban—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00125	0.00441	CcSEcCtD
Argatroban—Confusional state—Cladribine—multiple sclerosis	0.00125	0.0044	CcSEcCtD
Argatroban—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.00124	0.00438	CcSEcCtD
Argatroban—Infection—Cladribine—multiple sclerosis	0.00123	0.00434	CcSEcCtD
Argatroban—Haematuria—Mitoxantrone—multiple sclerosis	0.00122	0.00429	CcSEcCtD
Argatroban—Pulmonary oedema—Prednisone—multiple sclerosis	0.00121	0.00427	CcSEcCtD
Argatroban—Tachycardia—Cladribine—multiple sclerosis	0.00121	0.00426	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—IL1B—multiple sclerosis	0.00121	0.0118	CbGpPWpGaD
Argatroban—Cardiac arrest—Triamcinolone—multiple sclerosis	0.00119	0.00419	CcSEcCtD
Argatroban—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.00119	0.00418	CcSEcCtD
Argatroban—Dermatitis bullous—Betamethasone—multiple sclerosis	0.00119	0.00418	CcSEcCtD
Argatroban—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00119	0.00418	CcSEcCtD
Argatroban—Sepsis—Prednisone—multiple sclerosis	0.00118	0.00416	CcSEcCtD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00118	0.0114	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00118	0.0114	CbGpPWpGaD
Argatroban—Bradycardia—Mitoxantrone—multiple sclerosis	0.00117	0.00411	CcSEcCtD
Argatroban—Cardiac failure—Betamethasone—multiple sclerosis	0.00116	0.0041	CcSEcCtD
Argatroban—Cardiac failure—Dexamethasone—multiple sclerosis	0.00116	0.0041	CcSEcCtD
Argatroban—Respiratory failure—Methotrexate—multiple sclerosis	0.00116	0.00408	CcSEcCtD
Argatroban—Hypotension—Cladribine—multiple sclerosis	0.00116	0.00408	CcSEcCtD
Argatroban—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00115	0.00406	CcSEcCtD
Argatroban—Haemorrhage—Mitoxantrone—multiple sclerosis	0.00115	0.00404	CcSEcCtD
Argatroban—Thrombophlebitis—Prednisone—multiple sclerosis	0.00114	0.00402	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—MMP9—multiple sclerosis	0.00114	0.0111	CbGpPWpGaD
Argatroban—Pulmonary embolism—Methotrexate—multiple sclerosis	0.00114	0.00401	CcSEcCtD
Argatroban—Dyspnoea—Cladribine—multiple sclerosis	0.00111	0.00389	CcSEcCtD
Argatroban—Cardiac arrest—Betamethasone—multiple sclerosis	0.00108	0.0038	CcSEcCtD
Argatroban—Cardiac arrest—Dexamethasone—multiple sclerosis	0.00108	0.0038	CcSEcCtD
Argatroban—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00107	0.00377	CcSEcCtD
Argatroban—F2—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00106	0.0103	CbGpPWpGaD
Argatroban—Pain—Cladribine—multiple sclerosis	0.00106	0.00374	CcSEcCtD
Argatroban—Constipation—Cladribine—multiple sclerosis	0.00106	0.00374	CcSEcCtD
Argatroban—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.00104	0.0101	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.00104	0.0101	CbGpPWpGaD
Argatroban—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00103	0.00364	CcSEcCtD
Argatroban—Myocardial infarction—Prednisolone—multiple sclerosis	0.00103	0.00362	CcSEcCtD
Argatroban—Feeling abnormal—Cladribine—multiple sclerosis	0.00102	0.0036	CcSEcCtD
Argatroban—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00101	0.00357	CcSEcCtD
Argatroban—Pulmonary oedema—Methotrexate—multiple sclerosis	0.00101	0.00357	CcSEcCtD
Argatroban—Cardiac failure—Prednisone—multiple sclerosis	0.00101	0.00357	CcSEcCtD
Argatroban—Infection—Azathioprine—multiple sclerosis	0.001	0.00353	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.001	0.00972	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL4—multiple sclerosis	0.001	0.0097	CbGpPWpGaD
Argatroban—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.00099	0.00348	CcSEcCtD
Argatroban—Sepsis—Methotrexate—multiple sclerosis	0.000989	0.00348	CcSEcCtD
Argatroban—Body temperature increased—Cladribine—multiple sclerosis	0.000981	0.00345	CcSEcCtD
Argatroban—Abdominal pain—Cladribine—multiple sclerosis	0.000981	0.00345	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000976	0.00947	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—ITGA4—multiple sclerosis	0.00097	0.00941	CbGpPWpGaD
Argatroban—Back pain—Mitoxantrone—multiple sclerosis	0.000967	0.0034	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.000961	0.00932	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.000961	0.00932	CbGpPWpGaD
Argatroban—Bradycardia—Prednisolone—multiple sclerosis	0.000959	0.00338	CcSEcCtD
Argatroban—Thrombophlebitis—Methotrexate—multiple sclerosis	0.000955	0.00336	CcSEcCtD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.000951	0.00923	CbGpPWpGaD
Argatroban—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000951	0.00335	CcSEcCtD
Argatroban—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000949	0.00334	CcSEcCtD
Argatroban—Haemoglobin—Prednisolone—multiple sclerosis	0.000947	0.00333	CcSEcCtD
Argatroban—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000946	0.00333	CcSEcCtD
Argatroban—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000944	0.00332	CcSEcCtD
Argatroban—Hypotension—Azathioprine—multiple sclerosis	0.000943	0.00332	CcSEcCtD
Argatroban—Haemorrhage—Prednisolone—multiple sclerosis	0.000942	0.00332	CcSEcCtD
Argatroban—Cardiac arrest—Prednisone—multiple sclerosis	0.000941	0.00331	CcSEcCtD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.000916	0.00889	CbGpPWpGaD
Argatroban—Hypersensitivity—Cladribine—multiple sclerosis	0.000914	0.00322	CcSEcCtD
Argatroban—F2—Syndecan-4-mediated signaling events—MMP9—multiple sclerosis	0.000907	0.0088	CbGpPWpGaD
Argatroban—Renal failure acute—Methotrexate—multiple sclerosis	0.000896	0.00315	CcSEcCtD
Argatroban—Bradycardia—Triamcinolone—multiple sclerosis	0.000882	0.0031	CcSEcCtD
Argatroban—Bradycardia—Methylprednisolone—multiple sclerosis	0.00088	0.0031	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000874	0.00848	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.000874	0.00848	CbGpPWpGaD
Argatroban—Cough—Mitoxantrone—multiple sclerosis	0.000872	0.00307	CcSEcCtD
Argatroban—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000871	0.00307	CcSEcCtD
Argatroban—Haemoglobin—Triamcinolone—multiple sclerosis	0.000871	0.00306	CcSEcCtD
Argatroban—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000869	0.00306	CcSEcCtD
Argatroban—Haemorrhage—Triamcinolone—multiple sclerosis	0.000866	0.00305	CcSEcCtD
Argatroban—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000864	0.00304	CcSEcCtD
Argatroban—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000863	0.00304	CcSEcCtD
Argatroban—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000863	0.00304	CcSEcCtD
Argatroban—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000858	0.00302	CcSEcCtD
Argatroban—Myocardial infarction—Betamethasone—multiple sclerosis	0.000858	0.00302	CcSEcCtD
Argatroban—Chest pain—Mitoxantrone—multiple sclerosis	0.000851	0.003	CcSEcCtD
Argatroban—Diarrhoea—Cladribine—multiple sclerosis	0.000849	0.00299	CcSEcCtD
Argatroban—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000844	0.00297	CcSEcCtD
Argatroban—F2—Hemostasis—CD58—multiple sclerosis	0.000835	0.00811	CbGpPWpGaD
Argatroban—F2—Hemostasis—MERTK—multiple sclerosis	0.000835	0.00811	CbGpPWpGaD
Argatroban—F2—Hemostasis—SELPLG—multiple sclerosis	0.000835	0.00811	CbGpPWpGaD
Argatroban—Feeling abnormal—Azathioprine—multiple sclerosis	0.000832	0.00293	CcSEcCtD
Argatroban—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000825	0.0029	CcSEcCtD
Argatroban—Confusional state—Mitoxantrone—multiple sclerosis	0.000823	0.0029	CcSEcCtD
Argatroban—Dizziness—Cladribine—multiple sclerosis	0.000821	0.00289	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—ALB—multiple sclerosis	0.000814	0.0079	CbGpPWpGaD
Argatroban—Infection—Mitoxantrone—multiple sclerosis	0.00081	0.00285	CcSEcCtD
Argatroban—Bradycardia—Dexamethasone—multiple sclerosis	0.0008	0.00282	CcSEcCtD
Argatroban—Bradycardia—Betamethasone—multiple sclerosis	0.0008	0.00282	CcSEcCtD
Argatroban—Abdominal pain—Azathioprine—multiple sclerosis	0.000798	0.00281	CcSEcCtD
Argatroban—Body temperature increased—Azathioprine—multiple sclerosis	0.000798	0.00281	CcSEcCtD
Argatroban—Tachycardia—Mitoxantrone—multiple sclerosis	0.000796	0.0028	CcSEcCtD
Argatroban—F2—Folate Metabolism—ICAM1—multiple sclerosis	0.000794	0.00771	CbGpPWpGaD
Argatroban—Haemoglobin—Dexamethasone—multiple sclerosis	0.00079	0.00278	CcSEcCtD
Argatroban—Haemoglobin—Betamethasone—multiple sclerosis	0.00079	0.00278	CcSEcCtD
Argatroban—Vomiting—Cladribine—multiple sclerosis	0.000789	0.00278	CcSEcCtD
Argatroban—Haemorrhage—Dexamethasone—multiple sclerosis	0.000786	0.00277	CcSEcCtD
Argatroban—Haemorrhage—Betamethasone—multiple sclerosis	0.000786	0.00277	CcSEcCtD
Argatroban—Angiopathy—Methylprednisolone—multiple sclerosis	0.000784	0.00276	CcSEcCtD
Argatroban—Rash—Cladribine—multiple sclerosis	0.000783	0.00275	CcSEcCtD
Argatroban—Dermatitis—Cladribine—multiple sclerosis	0.000782	0.00275	CcSEcCtD
Argatroban—Headache—Cladribine—multiple sclerosis	0.000778	0.00274	CcSEcCtD
Argatroban—Hypotension—Mitoxantrone—multiple sclerosis	0.000762	0.00268	CcSEcCtD
Argatroban—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000752	0.00265	CcSEcCtD
Argatroban—Myocardial infarction—Prednisone—multiple sclerosis	0.000747	0.00263	CcSEcCtD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000747	0.00725	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000747	0.00725	CbGpPWpGaD
Argatroban—Hypersensitivity—Azathioprine—multiple sclerosis	0.000744	0.00262	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.000743	0.00721	CbGpPWpGaD
Argatroban—Nausea—Cladribine—multiple sclerosis	0.000737	0.00259	CcSEcCtD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000737	0.00715	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000737	0.00715	CbGpPWpGaD
Argatroban—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK1—multiple sclerosis	0.000733	0.00711	CbGpPWpGaD
Argatroban—Back pain—Triamcinolone—multiple sclerosis	0.000729	0.00257	CcSEcCtD
Argatroban—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000727	0.00256	CcSEcCtD
Argatroban—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000718	0.00253	CcSEcCtD
Argatroban—Angiopathy—Dexamethasone—multiple sclerosis	0.000713	0.00251	CcSEcCtD
Argatroban—Angiopathy—Betamethasone—multiple sclerosis	0.000713	0.00251	CcSEcCtD
Argatroban—F2—Folate Metabolism—CCL2—multiple sclerosis	0.000711	0.0069	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000705	0.00684	CbGpPWpGaD
Argatroban—Pain—Mitoxantrone—multiple sclerosis	0.000698	0.00246	CcSEcCtD
Argatroban—Constipation—Mitoxantrone—multiple sclerosis	0.000698	0.00246	CcSEcCtD
Argatroban—Bradycardia—Prednisone—multiple sclerosis	0.000697	0.00245	CcSEcCtD
Argatroban—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000691	0.00671	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000691	0.00671	CbGpPWpGaD
Argatroban—Diarrhoea—Azathioprine—multiple sclerosis	0.00069	0.00243	CcSEcCtD
Argatroban—Haemoglobin—Prednisone—multiple sclerosis	0.000688	0.00242	CcSEcCtD
Argatroban—Haemorrhage—Prednisone—multiple sclerosis	0.000685	0.00241	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.000685	0.00664	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000682	0.00662	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000682	0.00662	CbGpPWpGaD
Argatroban—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000672	0.00237	CcSEcCtD
Argatroban—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00067	0.0065	CbGpPWpGaD
Argatroban—Dizziness—Azathioprine—multiple sclerosis	0.000667	0.00235	CcSEcCtD
Argatroban—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000667	0.00235	CcSEcCtD
Argatroban—F2—GPCR ligand binding—S1PR1—multiple sclerosis	0.000666	0.00646	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.000663	0.00643	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—ALB—multiple sclerosis	0.000662	0.00643	CbGpPWpGaD
Argatroban—Cough—Triamcinolone—multiple sclerosis	0.000658	0.00232	CcSEcCtD
Argatroban—Tachycardia—Prednisolone—multiple sclerosis	0.000653	0.0023	CcSEcCtD
Argatroban—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000645	0.00227	CcSEcCtD
Argatroban—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000645	0.00227	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000644	0.00625	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000644	0.00625	CbGpPWpGaD
Argatroban—Vomiting—Azathioprine—multiple sclerosis	0.000642	0.00226	CcSEcCtD
Argatroban—Pneumonia—Methotrexate—multiple sclerosis	0.000641	0.00226	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.000636	0.00618	CbGpPWpGaD
Argatroban—Rash—Azathioprine—multiple sclerosis	0.000636	0.00224	CcSEcCtD
Argatroban—Dermatitis—Azathioprine—multiple sclerosis	0.000636	0.00224	CcSEcCtD
Argatroban—Headache—Azathioprine—multiple sclerosis	0.000632	0.00223	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000631	0.00612	CbGpPWpGaD
Argatroban—Angiopathy—Prednisone—multiple sclerosis	0.000621	0.00219	CcSEcCtD
Argatroban—Confusional state—Methylprednisolone—multiple sclerosis	0.000619	0.00218	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.000619	0.00601	CbGpPWpGaD
Argatroban—Infection—Triamcinolone—multiple sclerosis	0.000611	0.00215	CcSEcCtD
Argatroban—Infection—Methylprednisolone—multiple sclerosis	0.00061	0.00215	CcSEcCtD
Argatroban—Haematuria—Methotrexate—multiple sclerosis	0.000608	0.00214	CcSEcCtD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000605	0.00587	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000605	0.00587	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IFNG—multiple sclerosis	0.000604	0.00587	CbGpPWpGaD
Argatroban—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000601	0.00212	CcSEcCtD
Argatroban—Tachycardia—Triamcinolone—multiple sclerosis	0.000601	0.00211	CcSEcCtD
Argatroban—Nausea—Azathioprine—multiple sclerosis	0.000599	0.00211	CcSEcCtD
Argatroban—Tachycardia—Methylprednisolone—multiple sclerosis	0.000599	0.00211	CcSEcCtD
Argatroban—Haemoglobin—Methotrexate—multiple sclerosis	0.000575	0.00202	CcSEcCtD
Argatroban—Hypotension—Methylprednisolone—multiple sclerosis	0.000574	0.00202	CcSEcCtD
Argatroban—Pain—Prednisolone—multiple sclerosis	0.000572	0.00201	CcSEcCtD
Argatroban—Haemorrhage—Methotrexate—multiple sclerosis	0.000572	0.00201	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000565	0.00548	CbGpPWpGaD
Argatroban—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000558	0.00196	CcSEcCtD
Argatroban—Infection—Dexamethasone—multiple sclerosis	0.000555	0.00195	CcSEcCtD
Argatroban—Infection—Betamethasone—multiple sclerosis	0.000555	0.00195	CcSEcCtD
Argatroban—Feeling abnormal—Prednisolone—multiple sclerosis	0.000552	0.00194	CcSEcCtD
Argatroban—Dyspnoea—Triamcinolone—multiple sclerosis	0.000549	0.00193	CcSEcCtD
Argatroban—Tachycardia—Dexamethasone—multiple sclerosis	0.000545	0.00192	CcSEcCtD
Argatroban—Tachycardia—Betamethasone—multiple sclerosis	0.000545	0.00192	CcSEcCtD
Argatroban—Dyspepsia—Triamcinolone—multiple sclerosis	0.000542	0.00191	CcSEcCtD
Argatroban—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000541	0.0019	CcSEcCtD
Argatroban—F2—Folate Metabolism—IL1B—multiple sclerosis	0.000539	0.00523	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL2—multiple sclerosis	0.000537	0.00521	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—GPR65—multiple sclerosis	0.000537	0.00521	CbGpPWpGaD
Argatroban—Pain—Triamcinolone—multiple sclerosis	0.000526	0.00185	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000526	0.00511	CbGpPWpGaD
Argatroban—Hypotension—Betamethasone—multiple sclerosis	0.000522	0.00184	CcSEcCtD
Argatroban—Hypotension—Dexamethasone—multiple sclerosis	0.000522	0.00184	CcSEcCtD
Argatroban—Angiopathy—Methotrexate—multiple sclerosis	0.000519	0.00183	CcSEcCtD
Argatroban—Vomiting—Mitoxantrone—multiple sclerosis	0.000519	0.00183	CcSEcCtD
Argatroban—F2—Hemostasis—PLEK—multiple sclerosis	0.000516	0.00501	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.000514	0.00499	CbGpPWpGaD
Argatroban—Rash—Mitoxantrone—multiple sclerosis	0.000514	0.00181	CcSEcCtD
Argatroban—Dermatitis—Mitoxantrone—multiple sclerosis	0.000514	0.00181	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK1—multiple sclerosis	0.000513	0.00498	CbGpPWpGaD
Argatroban—Headache—Mitoxantrone—multiple sclerosis	0.000511	0.0018	CcSEcCtD
Argatroban—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000507	0.00179	CcSEcCtD
Argatroban—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000506	0.00178	CcSEcCtD
Argatroban—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000502	0.00177	CcSEcCtD
Argatroban—Hypersensitivity—Prednisolone—multiple sclerosis	0.000493	0.00174	CcSEcCtD
Argatroban—Dyspepsia—Betamethasone—multiple sclerosis	0.000492	0.00173	CcSEcCtD
Argatroban—Dyspepsia—Dexamethasone—multiple sclerosis	0.000492	0.00173	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CCR1—multiple sclerosis	0.000491	0.00476	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL13—multiple sclerosis	0.000491	0.00476	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—multiple sclerosis	0.000488	0.00474	CbGpPWpGaD
Argatroban—Body temperature increased—Triamcinolone—multiple sclerosis	0.000487	0.00171	CcSEcCtD
Argatroban—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000485	0.00171	CcSEcCtD
Argatroban—Nausea—Mitoxantrone—multiple sclerosis	0.000485	0.00171	CcSEcCtD
Argatroban—Infection—Prednisone—multiple sclerosis	0.000483	0.0017	CcSEcCtD
Argatroban—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000482	0.0017	CcSEcCtD
Argatroban—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000482	0.0017	CcSEcCtD
Argatroban—Back pain—Methotrexate—multiple sclerosis	0.000482	0.0017	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—TNF—multiple sclerosis	0.000481	0.00467	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.00048	0.00466	CbGpPWpGaD
Argatroban—Pain—Betamethasone—multiple sclerosis	0.000478	0.00168	CcSEcCtD
Argatroban—Pain—Dexamethasone—multiple sclerosis	0.000478	0.00168	CcSEcCtD
Argatroban—Tachycardia—Prednisone—multiple sclerosis	0.000475	0.00167	CcSEcCtD
Argatroban—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00046	0.00162	CcSEcCtD
Argatroban—Feeling abnormal—Betamethasone—multiple sclerosis	0.00046	0.00162	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000459	0.00446	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000457	0.00161	CcSEcCtD
Argatroban—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000457	0.00161	CcSEcCtD
Argatroban—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000453	0.0016	CcSEcCtD
Argatroban—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000452	0.00159	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.000443	0.0043	CbGpPWpGaD
Argatroban—Dizziness—Prednisolone—multiple sclerosis	0.000443	0.00156	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000442	0.00429	CbGpPWpGaD
Argatroban—Body temperature increased—Betamethasone—multiple sclerosis	0.000441	0.00155	CcSEcCtD
Argatroban—Body temperature increased—Dexamethasone—multiple sclerosis	0.000441	0.00155	CcSEcCtD
Argatroban—Abdominal pain—Betamethasone—multiple sclerosis	0.000441	0.00155	CcSEcCtD
Argatroban—Abdominal pain—Dexamethasone—multiple sclerosis	0.000441	0.00155	CcSEcCtD
Argatroban—Cough—Methotrexate—multiple sclerosis	0.000435	0.00153	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000428	0.00416	CbGpPWpGaD
Argatroban—Dyspepsia—Prednisone—multiple sclerosis	0.000428	0.00151	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000427	0.00414	CbGpPWpGaD
Argatroban—Chest pain—Methotrexate—multiple sclerosis	0.000424	0.00149	CcSEcCtD
Argatroban—Rash—Prednisolone—multiple sclerosis	0.000422	0.00149	CcSEcCtD
Argatroban—Dermatitis—Prednisolone—multiple sclerosis	0.000422	0.00148	CcSEcCtD
Argatroban—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00042	0.00148	CcSEcCtD
Argatroban—Headache—Prednisolone—multiple sclerosis	0.000419	0.00148	CcSEcCtD
Argatroban—Constipation—Prednisone—multiple sclerosis	0.000416	0.00146	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000415	0.00403	CbGpPWpGaD
Argatroban—Confusional state—Methotrexate—multiple sclerosis	0.00041	0.00144	CcSEcCtD
Argatroban—Dizziness—Triamcinolone—multiple sclerosis	0.000407	0.00143	CcSEcCtD
Argatroban—Dizziness—Methylprednisolone—multiple sclerosis	0.000406	0.00143	CcSEcCtD
Argatroban—F2—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000406	0.00394	CbGpPWpGaD
Argatroban—Infection—Methotrexate—multiple sclerosis	0.000404	0.00142	CcSEcCtD
Argatroban—Feeling abnormal—Prednisone—multiple sclerosis	0.000401	0.00141	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.000399	0.00387	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000398	0.0014	CcSEcCtD
Argatroban—Nausea—Prednisolone—multiple sclerosis	0.000398	0.0014	CcSEcCtD
Argatroban—Vomiting—Triamcinolone—multiple sclerosis	0.000391	0.00138	CcSEcCtD
Argatroban—F2—Folate Metabolism—TNF—multiple sclerosis	0.000391	0.0038	CbGpPWpGaD
Argatroban—Vomiting—Methylprednisolone—multiple sclerosis	0.00039	0.00137	CcSEcCtD
Argatroban—Rash—Triamcinolone—multiple sclerosis	0.000388	0.00137	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—IL6—multiple sclerosis	0.000388	0.00377	CbGpPWpGaD
Argatroban—Dermatitis—Triamcinolone—multiple sclerosis	0.000388	0.00136	CcSEcCtD
Argatroban—Rash—Methylprednisolone—multiple sclerosis	0.000387	0.00136	CcSEcCtD
Argatroban—Dermatitis—Methylprednisolone—multiple sclerosis	0.000387	0.00136	CcSEcCtD
Argatroban—Headache—Triamcinolone—multiple sclerosis	0.000386	0.00136	CcSEcCtD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000385	0.00373	CbGpPWpGaD
Argatroban—Headache—Methylprednisolone—multiple sclerosis	0.000385	0.00135	CcSEcCtD
Argatroban—Abdominal pain—Prednisone—multiple sclerosis	0.000384	0.00135	CcSEcCtD
Argatroban—Body temperature increased—Prednisone—multiple sclerosis	0.000384	0.00135	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000383	0.00372	CbGpPWpGaD
Argatroban—Diarrhoea—Dexamethasone—multiple sclerosis	0.000382	0.00134	CcSEcCtD
Argatroban—Diarrhoea—Betamethasone—multiple sclerosis	0.000382	0.00134	CcSEcCtD
Argatroban—Hypotension—Methotrexate—multiple sclerosis	0.00038	0.00134	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000376	0.00365	CbGpPWpGaD
Argatroban—Dizziness—Betamethasone—multiple sclerosis	0.000369	0.0013	CcSEcCtD
Argatroban—Dizziness—Dexamethasone—multiple sclerosis	0.000369	0.0013	CcSEcCtD
Argatroban—Nausea—Triamcinolone—multiple sclerosis	0.000366	0.00129	CcSEcCtD
Argatroban—Nausea—Methylprednisolone—multiple sclerosis	0.000365	0.00128	CcSEcCtD
Argatroban—F2—Hemostasis—SELE—multiple sclerosis	0.000364	0.00353	CbGpPWpGaD
Argatroban—Dyspnoea—Methotrexate—multiple sclerosis	0.000362	0.00128	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000361	0.00351	CbGpPWpGaD
Argatroban—Hypersensitivity—Prednisone—multiple sclerosis	0.000358	0.00126	CcSEcCtD
Argatroban—Dyspepsia—Methotrexate—multiple sclerosis	0.000358	0.00126	CcSEcCtD
Argatroban—Vomiting—Betamethasone—multiple sclerosis	0.000355	0.00125	CcSEcCtD
Argatroban—Vomiting—Dexamethasone—multiple sclerosis	0.000355	0.00125	CcSEcCtD
Argatroban—Rash—Dexamethasone—multiple sclerosis	0.000352	0.00124	CcSEcCtD
Argatroban—Rash—Betamethasone—multiple sclerosis	0.000352	0.00124	CcSEcCtD
Argatroban—Dermatitis—Dexamethasone—multiple sclerosis	0.000352	0.00124	CcSEcCtD
Argatroban—Dermatitis—Betamethasone—multiple sclerosis	0.000352	0.00124	CcSEcCtD
Argatroban—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000351	0.00124	CcSEcCtD
Argatroban—Headache—Dexamethasone—multiple sclerosis	0.00035	0.00123	CcSEcCtD
Argatroban—Headache—Betamethasone—multiple sclerosis	0.00035	0.00123	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CCL3—multiple sclerosis	0.00035	0.00339	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000348	0.00338	CbGpPWpGaD
Argatroban—Pain—Methotrexate—multiple sclerosis	0.000348	0.00122	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000345	0.00335	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—S1PR1—multiple sclerosis	0.000342	0.00332	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—PTGER4—multiple sclerosis	0.000337	0.00327	CbGpPWpGaD
Argatroban—Feeling abnormal—Methotrexate—multiple sclerosis	0.000335	0.00118	CcSEcCtD
Argatroban—Diarrhoea—Prednisone—multiple sclerosis	0.000333	0.00117	CcSEcCtD
Argatroban—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000332	0.00117	CcSEcCtD
Argatroban—Nausea—Betamethasone—multiple sclerosis	0.000332	0.00117	CcSEcCtD
Argatroban—Nausea—Dexamethasone—multiple sclerosis	0.000332	0.00117	CcSEcCtD
Argatroban—F2—Metabolism of proteins—PABPC1—multiple sclerosis	0.000328	0.00319	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCR3—multiple sclerosis	0.000325	0.00315	CbGpPWpGaD
Argatroban—Dizziness—Prednisone—multiple sclerosis	0.000322	0.00113	CcSEcCtD
Argatroban—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000321	0.00312	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000321	0.00312	CbGpPWpGaD
Argatroban—Abdominal pain—Methotrexate—multiple sclerosis	0.000321	0.00113	CcSEcCtD
Argatroban—Body temperature increased—Methotrexate—multiple sclerosis	0.000321	0.00113	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—RGS1—multiple sclerosis	0.00032	0.0031	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000317	0.00308	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000317	0.00308	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCR2—multiple sclerosis	0.000316	0.00307	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL6—multiple sclerosis	0.000316	0.00306	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000312	0.00303	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000311	0.00302	CbGpPWpGaD
Argatroban—Vomiting—Prednisone—multiple sclerosis	0.000309	0.00109	CcSEcCtD
Argatroban—Rash—Prednisone—multiple sclerosis	0.000307	0.00108	CcSEcCtD
Argatroban—Dermatitis—Prednisone—multiple sclerosis	0.000306	0.00108	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000305	0.00296	CbGpPWpGaD
Argatroban—Headache—Prednisone—multiple sclerosis	0.000305	0.00107	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—GPR65—multiple sclerosis	0.000303	0.00294	CbGpPWpGaD
Argatroban—Hypersensitivity—Methotrexate—multiple sclerosis	0.000299	0.00105	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000297	0.00288	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—RPL5—multiple sclerosis	0.000296	0.00287	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000293	0.00284	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CNR1—multiple sclerosis	0.000292	0.00283	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—RGS1—multiple sclerosis	0.00029	0.00282	CbGpPWpGaD
Argatroban—Nausea—Prednisone—multiple sclerosis	0.000289	0.00102	CcSEcCtD
Argatroban—Diarrhoea—Methotrexate—multiple sclerosis	0.000278	0.000979	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000277	0.00269	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR1—multiple sclerosis	0.000277	0.00269	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GPR65—multiple sclerosis	0.000275	0.00267	CbGpPWpGaD
Argatroban—Dizziness—Methotrexate—multiple sclerosis	0.000269	0.000946	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000268	0.0026	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LINGO1—multiple sclerosis	0.000266	0.00258	CbGpPWpGaD
Argatroban—F2—Hemostasis—ITGA4—multiple sclerosis	0.000263	0.00255	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000263	0.00255	CbGpPWpGaD
Argatroban—F2—Hemostasis—IFNB1—multiple sclerosis	0.000261	0.00253	CbGpPWpGaD
Argatroban—Vomiting—Methotrexate—multiple sclerosis	0.000258	0.00091	CcSEcCtD
Argatroban—Rash—Methotrexate—multiple sclerosis	0.000256	0.000902	CcSEcCtD
Argatroban—Dermatitis—Methotrexate—multiple sclerosis	0.000256	0.000901	CcSEcCtD
Argatroban—Headache—Methotrexate—multiple sclerosis	0.000255	0.000896	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000252	0.00244	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR1—multiple sclerosis	0.000252	0.00244	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL13—multiple sclerosis	0.000252	0.00244	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000251	0.00244	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000251	0.00243	CbGpPWpGaD
Argatroban—Nausea—Methotrexate—multiple sclerosis	0.000241	0.00085	CcSEcCtD
Argatroban—F2—Signaling Pathways—TAGAP—multiple sclerosis	0.000231	0.00224	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL5—multiple sclerosis	0.000226	0.0022	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—BCHE—multiple sclerosis	0.000217	0.0021	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000214	0.00208	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000209	0.00203	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000205	0.00199	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000204	0.00198	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCR5—multiple sclerosis	0.000204	0.00198	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—S1PR1—multiple sclerosis	0.000202	0.00196	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GPC5—multiple sclerosis	0.000196	0.00191	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00019	0.00185	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000184	0.00178	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2RA—multiple sclerosis	0.00018	0.00174	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL3—multiple sclerosis	0.000179	0.00174	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000179	0.00173	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000173	0.00168	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RGS1—multiple sclerosis	0.000172	0.00167	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000168	0.00163	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SRM—multiple sclerosis	0.000168	0.00163	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000167	0.00162	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000165	0.0016	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GPR65—multiple sclerosis	0.000163	0.00158	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR2—multiple sclerosis	0.000162	0.00157	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00016	0.00155	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000159	0.00155	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—POMC—multiple sclerosis	0.000159	0.00155	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000156	0.00152	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL2—multiple sclerosis	0.000156	0.00151	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—POMC—multiple sclerosis	0.000156	0.00151	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CNR1—multiple sclerosis	0.00015	0.00145	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR1—multiple sclerosis	0.000149	0.00144	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL13—multiple sclerosis	0.000149	0.00144	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000148	0.00144	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000136	0.00132	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000135	0.00131	CbGpPWpGaD
Argatroban—F2—Hemostasis—ALB—multiple sclerosis	0.00013	0.00126	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000128	0.00124	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000123	0.00119	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	0.000118	0.00115	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	0.000118	0.00115	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL5—multiple sclerosis	0.000116	0.00113	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000115	0.00112	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000113	0.0011	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—POMC—multiple sclerosis	0.000112	0.00109	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CCL2—multiple sclerosis	0.00011	0.00106	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPC5—multiple sclerosis	0.000108	0.00105	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL3—multiple sclerosis	0.000106	0.00103	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—multiple sclerosis	0.000105	0.00102	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR5—multiple sclerosis	0.000105	0.00101	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000103	0.001	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTGER4—multiple sclerosis	0.000102	0.00099	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PGR—multiple sclerosis	0.0001	0.000975	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCR3—multiple sclerosis	9.85e-05	0.000956	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CD28—multiple sclerosis	9.76e-05	0.000947	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR2—multiple sclerosis	9.59e-05	0.00093	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—POMC—multiple sclerosis	9e-05	0.000873	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—RRM1—multiple sclerosis	8.96e-05	0.00087	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CNR1—multiple sclerosis	8.85e-05	0.000859	CbGpPWpGaD
Argatroban—F2—Hemostasis—TGFB1—multiple sclerosis	8.21e-05	0.000797	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—POMC—multiple sclerosis	8.17e-05	0.000793	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK1—multiple sclerosis	8.05e-05	0.000782	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL2—multiple sclerosis	8e-05	0.000776	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL10—multiple sclerosis	7.97e-05	0.000773	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SRM—multiple sclerosis	7.8e-05	0.000757	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—TYK2—multiple sclerosis	7.26e-05	0.000705	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—POMC—multiple sclerosis	7.23e-05	0.000702	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CD86—multiple sclerosis	6.97e-05	0.000676	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL5—multiple sclerosis	6.86e-05	0.000665	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—multiple sclerosis	6.65e-05	0.000646	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SPP1—multiple sclerosis	6.35e-05	0.000616	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR5—multiple sclerosis	6.18e-05	0.0006	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2RA—multiple sclerosis	6.09e-05	0.000591	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—multiple sclerosis	6.04e-05	0.000586	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOE—multiple sclerosis	5.62e-05	0.000545	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5.5e-05	0.000534	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5.5e-05	0.000534	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—BCHE—multiple sclerosis	5.15e-05	0.0005	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CD80—multiple sclerosis	5.08e-05	0.000493	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPC5—multiple sclerosis	5.03e-05	0.000488	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—POMC—multiple sclerosis	4.83e-05	0.000469	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL2—multiple sclerosis	4.72e-05	0.000458	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK1—multiple sclerosis	4.62e-05	0.000449	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TYK2—multiple sclerosis	4.29e-05	0.000416	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.17e-05	0.000404	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—multiple sclerosis	3.57e-05	0.000346	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—multiple sclerosis	3.55e-05	0.000345	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—multiple sclerosis	3.38e-05	0.000328	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOE—multiple sclerosis	3.1e-05	0.000301	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—multiple sclerosis	3e-05	0.000291	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—multiple sclerosis	2.79e-05	0.000271	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TGFB1—multiple sclerosis	2.78e-05	0.00027	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK1—multiple sclerosis	2.73e-05	0.000265	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—POMC—multiple sclerosis	2.66e-05	0.000258	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALB—multiple sclerosis	2.43e-05	0.000235	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.39e-05	0.000232	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—multiple sclerosis	2.1e-05	0.000204	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOE—multiple sclerosis	1.44e-05	0.00014	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—POMC—multiple sclerosis	1.24e-05	0.00012	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALB—multiple sclerosis	1.13e-05	0.000109	CbGpPWpGaD
